Beth Hecht Iterum Therapeutics PLC (ITRM) insider trading activity

ITRM Quotes by TradingView

Beth Hecht is Director of Iterum Therapeutics plc. Currently has a direct ownership of 18,839 shares of ITRM, which is worth approximately $39,750. The most recent transaction as insider was on Jun 15, 2023, when has been sold 15,853 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.8K
0% 3M change
0% 12M change
Total Value Held $39,750

Beth Hecht Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
15,853 Added 45.7%
18,839 Ordinary Shares
Jun 23 2022
BUY
Exercise of conversion of derivative security
-
36,798 Added 45.09%
44,805 Ordinary Shares
Mar 18 2022
BUY
Exercise of conversion of derivative security
-
7,642 Added 48.83%
8,007 Ordinary Shares

Also insider at

XERS
XERIS PHARMACEUTICALS INC Healthcare
Officer
AYTU
AYTU BIOPHARMA, INC Healthcare
Director
XERS
Xeris Biopharma Holdings, Inc. Healthcare
Officer
BH

Beth Hecht

Director
Chicago, IL

Track Institutional and Insider Activities on ITRM

Follow Iterum Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITRM shares.

Notify only if

Insider Trading

Get notified when an Iterum Therapeutics PLC insider buys or sells ITRM shares.

Notify only if

News

Receive news related to Iterum Therapeutics plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITRM